Alpine Immune Sciences
0 sources
Alpine Immune Sciences
Summary
Alpine Immune Sciences is a business[1].
Key Facts
- Alpine Immune Sciences is in the country of United States[2].
- Alpine Immune Sciences is in the country of US[3].
- Alpine Immune Sciences's instance of is recorded as business[4].
- Alpine Immune Sciences's stock exchange is recorded as Nasdaq[5].
- Alpine Immune Sciences's industry is recorded as pharmaceutical industry[6].
- January 1, 2015 marks the founding of Alpine Immune Sciences[7].
- 2014-12-29 marks the founding of Alpine Immune Sciences[8].
- Alpine Immune Sciences's coordinate location is recorded as {'globe': 'http://www.wikidata.org/entity/Q2', 'altitude': None, 'latitude': 47.635092, 'longitude': -122.3285349, 'precision': 1e-07}[9].
- Alpine Immune Sciences's official website is recorded as https://www.alpineimmunesciences.com/[10].
- Alpine Immune Sciences's legal form is recorded as Delaware corporation[11].
- Alpine Immune Sciences's legal form is recorded as XTIQ[12].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300IMIDW5YH1N0R10[13]
-
Registered legal name: Ais Operating Co., INC.[14]
-
Legal jurisdiction: US-DE[15]
-
GLEIF entity category: GENERAL[16]
-
Legal form (ISO 20275 ELF): XTIQ[17]
-
Entity status: ACTIVE[18]
-
LEI registration status: LAPSED[19]
-
Entity created: 2014-12-29[20]
-
LEI first registered: 2017-07-18[21]
-
LEI last updated: 2023-08-04[22]
-
LEI next renewal: 2018-07-14[23]
-
Managing LOU: 5493001KJTIIGC8Y1R12[24]
-
Registration authority: RA000602[25]
-
Authority entity ID: 5666489[26]
-
Other names: Alpine Immune Sciences, Inc.[27]
-
Conformity flag: NON_CONFORMING[28]
Body
Founding
Recorded inception include January 1, 2015[7] and 2014-12-29[8].
Industry
Alpine Immune Sciences's industry is recorded as pharmaceutical industry[6].
Ownership
Alpine Immune Sciences's stock exchange is recorded as Nasdaq[5].